Status:
COMPLETED
To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fasting Conditions
Lead Sponsor:
Sandoz
Conditions:
Inflammation
Eligibility:
MALE
18-40 years
Phase:
PHASE1
Brief Summary
To demonstrate the relative bioavailability of Diclofenac Sodium 50 mg enteric-coated tablets under non-fasting conditions.
Eligibility Criteria
Inclusion
- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
Exclusion
- Positive test results for HIV or hepatitis B or C.
- Treatment for drug or alcohol dependence.
Key Trial Info
Start Date :
August 1 1993
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 1993
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00914160
Start Date
August 1 1993
End Date
September 1 1993
Last Update
March 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.